Helper virus-free herpes simplex virus-1 plasmid vectors for gene therapy of Parkinson's disease and other neurological disorders

Experimental Neurology

Volumn 144, Issue 1, 1997, Pages 98-102

  Geller, Alfred I ^a,b   Yu, Linda ^a   Wang, Yaming ^a   Fraefel, Cornel ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMID VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CIRCLING BEHAVIOR; CORPUS STRIATUM; GENE THERAPY; HERPES SIMPLEX VIRUS; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

EID: 0031104710     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1996.6394     Document Type: Article

References (26)

1. 1. BATTLEMAN, D. S., A. I. GELLER, AND M. V. CHAO. 1993. HSV-1 vector mediated gene transfer of the human nerve growth factor receptor p75hNGFR defines high affinity NGF binding. J. Neurosci. 13: 941-951.
2. 2. BERGOLD, P. J., P. CASACCIA-BONNEFIL, Z. XIU-LIU, AND H. J. FEDEROFF. 1993. Transsynaptic neuronal loss induced in hippocampal slice cultures by a herpes simplex virus vector expressing the GluR6 subunit of the kainate receptor. Proc. Natl. Acad. Sci. USA 90: 6165-6169.
3. 3. CUNNINGHAM, C., AND A. J. DAVISON. 1993. A cosmid-based system for constructing mutants of herpes simplex virus type 1. Virology 197: 116-124.
4. 4. DAVIDSON, I., AND N. D. STOW. 1985. Expression of an immediate early polypeptide and activation of a viral origin of DNA replication in cells containing a fragment of herpes simplex virus DNA. Virology 141: 77-88.
5. 5. DELUCA, N. A., A. M. MCCARTHY, AND P. A. SCHAEFFER 1985. Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J. Virol. 56: 558-570.
6. 6. DURING, M. J., J. NAEGELE, K. O'MALLEY, AND A. I. GELLER, 1994. Long-term behavioral recovery in parkinsonian rats by an HSV-1 vector expressing tyrosine hydroxylase. Science 266: 1399-1403.
7. 7. FEDEROFF, H. J., M. D. GESCHWIND, A. I. GELLER, AND J. A. KESSLER. 1992. Expression of NGF in vivo, from a defective HSV-1 vector, prevents effects of axotomy on sympathetic neurons. Proc. Natl. Acad. Sci. USA 89: 1636-1640.
8. 8. FRAEFEL, C., S. SONG, F. LIM, P. LANG, L. Yu, Y. WANG, P. WILD, AND A. I. GELLER. 1996. A helper virus-free packaging system for HSV-1 plasmid vectors. J. Virol. 70: 7190-7197.
9. 9. GELLER, A. I., AND X. O. BREAKEFIELD. 1988. A defective HSV-1 vector expresses Escherichia coli β-galactosidase in cultured peripheral neurons. Science 241: 1667-1669.
10. 10. GELLER, A. I., AND A. FREESE. 1990. Infection of cultured central nervous system neurons with a defective herpes simplex virus 1 vector results in stable expression of Escherichia coli β-galactosidase. Proc. Natl. Acad. Sci. USA 87: 1149-1153.
11. 11. GELLER, A. I., K. KEYOMARSKI, J. BRYAN, AND A. B. PARDEE. 1990. An efficient deletion mutant packaging system for defective HSV-1 vectors: Potential applications to neuronal physiology and human gene therapy. Proc. Natl. Acad. Sci. USA 87: 8950-8954.
12. 12. GELLER, A. I., M. J. DURING, AND R. L. NEVE. 1991. Molecularanalysis of neuronal physiology by gene transfer into neurons with herpes simplex virus vectors. Trends Neurosci. 14: 428-432.
13. 13. GELLER, A. I., M. J. DURING, J. W. HAYCOCK, A. FREESE, AND R. L. NEVE. 1993. Long-term increases in neurotransmitter release from neuronal cells expressing a constitutively active adenylate cyclase from a HSV-1 vector. Proc. Natl. Acad. Sci. USA 90: 7603-7607.
14. 14. GELLER, A. I., A. FREESE, M. J. DURING, AND K. L. O'MALLEY. 1995. A HSV-1 vector expressing tyrosine hydroxylase causes production and release of L-dopa from cultured rat striatal cells. J. Neurochem. 64: 487-496.
15. 15. Ho, D. Y., E. S. MOCARSKI, AND R. M. SAPOLSKY. 1993. Altering central nervous system physiology with a defective HSV-1 vector expressing the glucose transporter gene. Proc. Natl. Acad. Sci. USA 90: 3655-3659.
16. 16. HORELLOU, P., P. BRUNDIN, P. KALEN, J. MALLET, AND A. BJORKLUND. 1990. In vivo release of DOPA and dopamine from genetically engineered cells grafted to the denervated rat striaturn. Neuron 5: 393-402.
17. 17. KANG, U. J., L. J. FISHER, H. A. JINNAH, T. H. ROSENBERG, T. JOH, F. H. FRIEDMANN, AND F. H. GAGE. 1991. Intracerebral grafting of AADC-expressing primary fibroblasts for site-specific delivery of dopamine. Abstr. Soc. Neurosci. 17: 424.12.
18. 18. KAPLITT, M. G., A. D. KWONG, S. P. KLEOPOULOS, C. V. MOBBS, S. D. RABKIN, AND D. W. PFAFF. 1994. Preproenkephalin promoter yields region-specific and long-term expression in adult brain after direct in vivo gene transfer via a defective herpes simplex viral vector. Proc. Natl. Acad. Sci. USA 91: 8979-8983.
19. 19. LIM, F., D. HARTLEY, P. STARR, P. LANG, S. SONG, L. Yu, Y. WANG, AND A. I. GELLER 1996. Packaging defective HSV-1 vectors using an IE 2 deletion mutant supports efficient expression in cultured cortical cells. Biotechniques 20: 460-470.
20. 20. MCCARTHY, A. M., L. MCMAHAN, AND P. A. SCHAFFER, 1989. Herpes simplex virus type 1 ICP27 deletion mutants exhibit altered patterns of transcription and are DNA deficient. J. Virol. 63: 18-27.
21. 21. MANN, R., R. L. MULLIGAN, AND D. BALTIMORE. 1983. Construction of retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell 33: 153-159.
22. 22. OH, Y. J., S. C. WONG, M. MOFFAT, D. ULLREY, A. I. GELLER, AND K. L. O'MALLEY. 1996. A herpes simplex virus-1 vector containing the rat tyrosine hydroxylase promoter directs cell-type specific expression of β-galactosidase in cultured rat peripheral neurons. Mol. Brain Res. 35: 227-236.
23. 23. PATTERSON, T., AND R. D. EVERETT. 1990. A prominent serine-rich region in Vmw175, the major transcriptional regulator protein of herpes simplex virus type 1, is not essential for virus growth in tissue culture. J. Gen. Virol. 71: 1775-1783.
24. 24. SMITH, I. L., M. A. HARDWICKE, AND R. M. SANDRI-GOLDIN. 1992. Evidence that the HSV immediate early protein ICP27 acts posttranscriptionally during infection to regulate gene expression. Virology 186: 74-86.
25. 25. SONG, S., Y. WANG, S. Y. BAK, P. LANG, D. ULLREY, R. L. NEVE, K. L. O'MALLEY, AND A. I. GELLER. 1996. A HSV-1 vector containing the rat tyrosine hydroxylase promoter enhances both long-term and cell type-specific expression in the midbrain. Submitted for publication.
26. 26. Xu, H., H. FEDEROFF, J. MARAGOS, L. F. PARADA, AND J. A. KESSLER. 1994. Viral transduction of trkA into cultured nodose and spinal motor neurons conveys NGF responsiveness. Dev. Biol. 163: 152-161.